News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
204,365 Results
Type
Article (20451)
Company Profile (104)
Press Release (183810)
Section
Business (64871)
Career Advice (1121)
Deals (9251)
Drug Delivery (75)
Drug Development (19384)
Employer Resources (147)
FDA (3583)
Job Trends (6141)
News (97639)
Policy (7439)
Tag
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1545)
Academic (2)
Accelerated approval (1)
Adcomms (16)
Allergies (21)
Alliances (17672)
ALS (27)
Alzheimer's disease (563)
Antibody-drug conjugate (ADC) (60)
Approvals (3585)
Artificial intelligence (125)
Autoimmune disease (7)
Automation (7)
Bankruptcy (53)
Best Places to Work (5021)
BIOSECURE Act (11)
Biosimilars (52)
Biotechnology (64)
Bladder cancer (23)
Brain cancer (6)
Breast cancer (88)
Cancer (608)
Cardiovascular disease (65)
Career advice (961)
Career pathing (32)
CAR-T (52)
Cell therapy (145)
Cervical cancer (8)
Clinical research (14731)
Collaboration (357)
Compensation (79)
Complete response letters (7)
COVID-19 (1035)
CRISPR (17)
C-suite (114)
Cystic fibrosis (38)
Data (610)
Decentralized trials (1)
Denatured (21)
Depression (18)
Diabetes (69)
Diagnostics (2389)
Digital health (6)
Diversity (7)
Diversity, equity & inclusion (40)
Drug discovery (54)
Drug pricing (51)
Drug shortages (6)
Duchenne muscular dystrophy (39)
Earnings (14933)
Editorial (15)
Employer branding (23)
Employer resources (125)
Events (30002)
Executive appointments (364)
FDA (3896)
Featured Employer (33)
Friedreich's ataxia (2)
Frontotemporal dementia (3)
Funding (338)
Gene editing (36)
Generative AI (14)
Gene therapy (104)
GLP-1 (312)
Government (1397)
Guidances (17)
Healthcare (5126)
Huntington's disease (13)
IgA nephropathy (9)
Immunology and inflammation (26)
Indications (6)
Infectious disease (1094)
Inflammatory bowel disease (56)
Inflation Reduction Act (7)
Influenza (19)
Intellectual property (28)
Interviews (169)
IPO (3700)
IRA (20)
Job creations (1333)
Job search strategy (828)
Kidney cancer (1)
Labor market (31)
Layoffs (166)
Leadership (11)
Legal (1261)
Liver cancer (21)
Lung cancer (93)
Lymphoma (52)
Machine learning (1)
Management (45)
Manufacturing (119)
MASH (14)
Medical device (2749)
Medtech (2753)
Mergers & acquisitions (5773)
Metabolic disorders (215)
Multiple sclerosis (39)
NASH (9)
Neurodegenerative disease (29)
Neuropsychiatric disorders (6)
Neuroscience (752)
NextGen: Class of 2025 (2205)
Non-profit (1730)
Northern California (768)
Now hiring (36)
Obesity (136)
Opinion (109)
Ovarian cancer (22)
Pain (33)
Pancreatic cancer (14)
Parkinson's disease (43)
Partnered (12)
Patents (49)
Patient recruitment (23)
Peanut (15)
People (27276)
Pharmaceutical (25)
Pharmacy benefit managers (1)
Phase I (4297)
Phase II (6080)
Phase III (5884)
Pipeline (296)
Podcasts (29)
Policy (56)
Postmarket research (598)
Preclinical (2438)
Press Release (61)
Prostate cancer (23)
Psychedelics (18)
Radiopharmaceuticals (65)
Rare diseases (123)
Real estate (2553)
Recruiting (56)
Regulatory (5358)
Reports (35)
Research institute (1296)
Resumes & cover letters (169)
Rett syndrome (3)
RNA editing (1)
RSV (25)
Schizophrenia (27)
Series A (72)
Series B (41)
Service/supplier (8)
Sickle cell disease (22)
Southern California (543)
Special edition (8)
Spinal muscular atrophy (53)
Sponsored (15)
Startups (2024)
State (1)
Stomach cancer (6)
Supply chain (21)
Tariffs (3)
The Weekly (8)
United States (6594)
Vaccines (208)
Venture capitalists (28)
Webinars (9)
Weight loss (99)
Women's health (13)
Worklife (15)
Date
Today (38)
Last 7 days (211)
Last 30 days (837)
Last 365 days (10913)
2025 (2739)
2024 (11715)
2023 (13255)
2022 (15952)
2021 (18179)
2020 (16789)
2019 (15518)
2018 (11209)
2017 (10656)
2016 (10539)
2015 (11256)
2014 (8280)
2013 (7149)
2012 (7589)
2011 (7784)
2010 (7214)
Location
Africa (366)
Alabama (21)
Alaska (4)
Arizona (62)
Arkansas (4)
Asia (11493)
Australia (2048)
California (1627)
Canada (588)
China (137)
Colorado (92)
Connecticut (78)
Delaware (70)
Europe (29848)
Florida (249)
Georgia (53)
Hawaii (1)
Idaho (12)
Illinois (129)
India (17)
Indiana (140)
Iowa (5)
Japan (62)
Kansas (27)
Kentucky (7)
Louisiana (4)
Maine (6)
Maryland (195)
Massachusetts (1356)
Michigan (91)
Minnesota (107)
Mississippi (1)
Missouri (30)
Montana (4)
Nebraska (9)
Nevada (12)
New Hampshire (13)
New Jersey (549)
New Mexico (16)
New York (637)
North Carolina (320)
North Dakota (7)
Northern California (768)
Ohio (63)
Oklahoma (7)
Oregon (15)
Pennsylvania (286)
Puerto Rico (3)
Rhode Island (8)
South America (432)
South Carolina (6)
Southern California (543)
Tennessee (31)
Texas (214)
Utah (42)
Virginia (40)
Washington D.C. (25)
Washington State (134)
Wisconsin (30)
204,365 Results for "exact sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Exact Sciences Schedules First Quarter 2025 Earnings Call
April 1, 2025
·
1 min read
Press Releases
Exact Sciences to Participate in March Investor Conferences
February 24, 2025
·
1 min read
Press Releases
Exact Sciences Launches the Cologuard Plus™ Test, Transforming Colorectal Cancer Screening
March 31, 2025
·
8 min read
Press Releases
Exact Sciences Announces Fourth Quarter 2024 Results
February 19, 2025
·
19 min read
Press Releases
Exact Sciences Schedules Fourth Quarter 2024 Earnings Call
February 3, 2025
·
1 min read
Press Releases
New Data Highlight the Positive Impact of Exact Sciences’ Oncotype DX® Test on Patient Care and Healthcare Efficiency
March 12, 2025
·
5 min read
Press Releases
Exact Sciences to Participate in J.P. Morgan Healthcare Conference
January 2, 2025
·
1 min read
Press Releases
Flatiron Health and Exact Sciences Partner to Advance Clinical Evidence Generation for Molecular Residual Disease Testing
February 5, 2025
·
4 min read
Press Releases
Exact Sciences to Participate in December 2024 Investor Conferences
November 26, 2024
·
1 min read
Business
Exact Sciences Announces First-Quarter 2024 Results
Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of $638 million for the first quarter ended March 31, 2024, compared to $602 million for the same period of 2023.
May 8, 2024
·
21 min read
1 of 20,437
Next
